events & webinars

Bebi Therapeutics

Developing derivatives of a small molecule isolated from bacterial consortia from non-small cell lung cancer patients that causes immune checkpoint inhibitor non-responders to become responsive to immune checkpoint inhibitor therapies
Non-confidential slide deck available upon request
Seeking seed funding

When:

Where:

Event Type

Event Organizer

Event Category

Instructions on how to participate here, whether it is to purchase tickets or register.

Gain visibility, build valuable relationships, and make a lasting impact. Partner with us to sponsor an event today